ÂÜÀòÂÒÂ×

Serge SAGODIRA has a diverse work experience spanning over several companies and roles. Serge is currently the Chief Business Officer at Ariceum Therapeutics, a position they have held since July 2022. Prior to this, Serge worked at Debiopharm from 2018 to 2022, first as the Director Licensing Transactions and later as the Head of Transactions in Business Development and Licensing. From 2016 to 2018, they served as the Director of Business Development at the Drugs for Neglected Diseases initiative - DNDi. At Debiopharm International SA, Serge held various roles, including Head of Licensing, Head of Alliances and Licensing, Head of Asia & Europe in Search and Licensing, and Senior Search & Evaluation Officer in In Licensing, from 2011 to 2016. Before that, they were a Business Development Manager at Addex Pharmaceuticals from 2006 to 2011 and a Licensing Associate at Pactt CHUV/UNIL in 2006. Serge began their career as a Business Manager at FIST S.A. from 2003 to 2005 and as a Business Development Manager and R&D Projects Coordinator at VIRSOL from 1998 to 2003.

Serge Sagodira's education history includes earning a PhD in Life Sciences from the Université de Tours. Serge attended this university from 1994 to 1998. Prior to that, they studied at the Ecole Française de Bangkok from 1980 to 1985, although it is not specified what degree or field of study they pursued during that time.